StructureMoa ↔ BioMoa 브리지
단순 아웃링크가 아니라 공유 ID(sm:…|bm:…)로 패밀리와 프로그램을 맞춥니다. 구조 맵은 StructureMoa, 임상·파이프라인은 BioMoa.
선택 패밀리
공유 ID: sm:ms-s1p-modulator|bm:cns
| StructureMoa 패밀리 | 카테고리 | 공유 ID | BioMoa |
|---|---|---|---|
| ADHD stimulant / non-stimulant series | ADHD | sm:adhd-stimulant|bm:oncogene-tki | oncogene-tki |
| ALS neuroprotectant series | ALS | sm:als-neuroprotectant|bm:cns | cns |
| Antiepileptic drug chemical series | 항경련·AED | sm:antiepileptic-series|bm:cns | cns |
| Atypical antipsychotic series | 정신분열·비전형 AP | sm:atypical-antipsychotic|bm:cns | cns |
| Benzodiazepine GABA-A modulators | 불안·GABA | sm:benzodiazepine-series|bm:cns | cns |
| Cognitive modulator series | 인지·치매 | sm:cognitive-modulator-series|bm:cns | cns |
| Migraine triptan series | 편두통·triptan | sm:migraine-triptan|bm:cns | cns |
| MS S1P modulator series | 다발성경화·S1P | sm:ms-s1p-modulator|bm:cns | cns |
| Neuropathic gabapentinoid / SNRI series | 신경병증·gabapentinoid | sm:neuropathic-gabapentinoid|bm:cns | cns |
| Parkinson dopaminergic / MAO-B series | 파킨슨 | sm:parkinson-dopaminergic|bm:cns | cns |
| Sleep / hypnotic series | 수면·hypnotic | sm:sleep-hypnotic|bm:cns | cns |
| SSRI / SNRI antidepressant series | 항우울·SSRI/SNRI | sm:ssri-snri-series|bm:cns | cns |
| ADC linker chemical families | ADC linker | sm:adc-linkers|bm:her2-breast | her2-breast |
| ALK / ROS1 TKI chemical series | ALK / ROS1 TKI | sm:alk-inhibitors|bm:alk | alk |
| BCL-2 BH3-mimetic inhibitor series | BCL-2 inhibitor | sm:bcl2-inhibitors|bm:oncogene-tki | oncogene-tki |
| BCR-ABL TKI chemical series | BCR-ABL TKI | sm:bcr-abl-tki|bm:bcr-abl | bcr-abl |
| BRAF / MEK inhibitor chemical series | BRAF / MEK | sm:braf-mek|bm:oncogene-tki | oncogene-tki |
| BTK inhibitor chemical series | BTK inhibitor | sm:btk-inhibitors|bm:btk | btk |
| CDK4/6 inhibitor chemical series | CDK4/6 inhibitor | sm:cdk46-inhibitors|bm:cdk4 | cdk4 |
| Daraxonrasib scaffold family | KRAS inhibitor | sm:daraxonrasib|bm:kras-g12c | kras-g12c |
| DM1 / maytansinoid payload family | Maytansinoid | sm:dm1|bm:her2-breast | her2-breast |
| Duocarmycin CPI ADC payload series | ADC payload | sm:duocarmycin-payloads|bm:alk | alk |
| EGFR tyrosine kinase inhibitor series | EGFR TKI | sm:egfr-inhibitors|bm:egfr | egfr |
| Exatecan / DXd (TOP1 inhibitor) payload family | TOP1 inhibitor | sm:exatecan-dxd|bm:her2-breast | her2-breast |
| GLP-1 / incretin agonist series | GLP-1 / incretin | sm:glp1-agonists|bm:oncogene-tki | oncogene-tki |
| JAK inhibitor chemical series | JAK inhibitor | sm:jak-inhibitors|bm:jak | jak |
| KRAS G12C inhibitor chemical landscape | KRAS inhibitor | sm:kras-g12c|bm:kras-g12c | kras-g12c |
| KRAS G12D / RAS(ON) inhibitor series | KRAS inhibitor | sm:kras-g12d|bm:kras-g12c | kras-g12c |
| MMAE (auristatin) payload family | ADC payload | sm:mmae|bm:her2-breast | her2-breast |
| PARP inhibitor chemical series | PARP inhibitor | sm:parp-inhibitors|bm:parp | parp |
| PBD dimer ADC payload family | ADC payload | sm:pbd-payloads|bm:cns | cns |
| PCSK9 inhibitor chemical & modality series | PCSK9 / LDL-C | sm:pcsk9-inhibitors|bm:pcsk9 | pcsk9 |
| PI3K / AKT / mTOR inhibitor series | PI3K / AKT / mTOR | sm:pi3k-akt-mtor|bm:pi3k-akt-mtor | pi3k-akt-mtor |
| PROTAC / bifunctional degrader series | PROTAC / degrader | sm:protac-degraders|bm:kras-g12c | kras-g12c |
| RET / MET / NTRK oncogene TKI series | RET / MET / NTRK TKI | sm:ret-met-ntrk|bm:oncogene-tki | oncogene-tki |
| SN-38 / irinotecan (TOP1) small-molecule series | TOP1 inhibitor | sm:sn38-irinotecan|bm:her2-breast | her2-breast |
| Taxane diterpenoid series | Taxane / microtubule | sm:taxanes|bm:microtubule | microtubule |